PharmaShots Weekly Snapshot (November 23-27, 2019)
Published: Nov 29, 2019 | Tags: Lymphoplasmacytic Lymphoma, MAA, MHLW, ONO, reports, Submission, Tirabrutinib Hydrochloride, Waldenstrom Macroglobulinemia
2. AstraZeneca Collaborates with JVP to Invest in Digital Health Program in Israel
Published: Nov 27, 2019 | Tags: AstraZeneca, Collaborates, Digital Health, Program, Invest, Israel, JVP
Published: Nov 29, 2019 | Tags: (durvalumab), Acceptance, AstraZeneca, Extensive-Stage Small Cell Lung Cancer, Granted, Imfinzi, Priority Review, Reports, sBLA, US FDA
4. WuXi ATU and GeneMedicine Collaborate to Develop and Manufacture Oncolytic Virus Products
Published: Nov 28, 2019 | Tags: Collaborate, Develop, GeneMedicine, Manufacture, Oncolytic Virus Products, WuXi ATU
Published: Nov 28, 2019 | Tags: Trastuzumab emtansine, Approval, Health Canada, HER2-Positive Early Breast Cancer, After, Surgery, Kadcyla, Receives, Roche
6. Avion Signs an Exclusive License Agreement with ImmuPharma to Develop and Commercialize Lupuzor
Published: Nov 29, 2019 | Tags: Avion, Commercialize, Develop, Exclusive, ImmuPharma, License Agreement, Lupuzor, Signs
Published: Nov 28, 2019 | Tags: 2020, Collaborates, Educational Programs, Expand, IBCI, India, Octavus Consulting
8. JW Pharma Acquires C&C Research Laboratories a Joint Venture with Chugai
Published: Nov 27, 2019 | Tags: C&C Research Laboratories, Chugai, Collaborate, Establish, Joint Venture, JW Pharma
9. Simcere Signs an Exclusive Regional Licensing Agreement with GI Innovation for its GI-101 Candidate
Published: Nov 28, 2019 | Tags: Agreement, Candidate, Exclusive, GI Innovation, GI-101, Licensing, Regional, Signs, Simcere
Published: Nov 27, 2019 | Tags: Approval, Boehringer Ingelheim, Canada, First Therapy, Health Canada, Nintedanib, Ofev, Receives, Ssc-Ild, Treat
Published: Nov 27, 2019 | Tags: Chugai, Japan, Launches, Optimal Formulation, PD-L1, Tecentriq Intravenous Infusion 840 mg, Treat, Triple-Negative Breast Cancer
12. Mochida Launches Teriparatide Biosimilar for the Treatment of Osteoporosis in Japan
Published: Nov 27, 2019 | Tags: Japan, Launches, Mochida, Osteoporosis, Teriparatide Biosimilar
Published: Nov 27, 2019 | Tags: AbbVie UK, Autoimmune Conditions, Collaborates, Exploring, Generate, NorthWest EHealth, Real-World Evidence
Published: Nov 27, 2019 | Tags: Acceptance, Cholangiocarcinoma, Incyte, NDA, patients, Pemigatinib, Priority Review, reports, Treat
Published: Nov 26, 2019 | Tags: Enzalutamide, Approval, Astellas, Castration-Resistant Prostate Cancer Men Metastatic, NMPA, Receives, Xtandi
16. Amazons Alexa Launches Medication Management Feature for Giant Eagles Clients
Published: Nov 26, 2019 | Tags: Alexa, Amazon, Giant Eagles Clients, Launches, Medication Management Feature
17. Elsevier Acquires 3D4Medical for ~$50M
Published: Nov 27, 2019 | Tags: ~50M, 3D4Medical, Acquires, Elsevier
18. Celltrions Remsima SC (biosimilar, infliximab) Receives ECs Approval for Rheumatoid Arthritis
Published: Nov 26, 2019 | Tags: (infliximab), approval, Biosimilar, Celltrion, EC, receives, Remsima SC
Published: Nov 27, 2019 | Tags: approval, Bengaluru, Biocon, Biosimilar, FDA, Fulphila, Manufactured, Mylan, New Facility, Pegfilgrastim, Report, sBLA, US
Published: Nov 26, 2019 | Tags: AstraZeneca, Collaborates, Develop, First, Heart Failure, Heart-in-a-Jar Model, Novoheart, World
Published: Nov 26, 2019 | Tags: Pembrolizumab, 1L, Treatment, Approval, Ct, Keytruda, Merck, Metastatic Squamous Non-Small Cell Lung Cancer, NMPA, Receives
22. Yas Holding Collaborates with Alvogen to Commercialize its Generic Portfolio in MENA Region
Published: Nov 25, 2019 | Tags: Alvogen, Collaborates, Commercialize, Generic Portfolio, MENA Region, Yas Holding
23. Kyowa Kirin Signs Two Agreement with Ardelyx to Expand its Existing Partnership
Published: Nov 25, 2019 | Tags: Ardelyx, Existing, Expand, Kyowa Kirin, Partnership, Signs, Two Agreement
24. Bayer Reports Submission of MAA to EMA for Rivaroxaban to Treat Venous Thromboembolism in Children
Published: Nov 25, 2019 | Tags: Bayer, Children, EMA, MAA, Reports, Rivaroxaban, Submission, Treat, Venous, Thromboembolism
Published: Nov 25, 2019 | Tags: Acceptance, Dravet Syndrome, FDA, fenfluramine, Fintepla, Granted, NDA, Priority Review, reports, US, Zogenix
Published: Nov 25, 2019 | Tags: Blackstone, Bladder Cancer, Collaborate, Ferring, Focusing, Gene Therapy, Joint Venture
Published: Nov 23, 2019 | Tags: Advanced, ALTA-1L, Alunbrig, Anaplastic Lymphoma Kinase Positive, brigatinib, Non-Small Cell Lung Cancer, P-III, reports, results, study, Takeda
Published: Nov 22, 2019 | Tags: Atezolizumab, Avastin, Bevacizumab, ESMO, Congress, 2019, Imbrave150, P-III, Reports, Results, Roche, Tecentriq, Unresectable, Hepatocellular Carcinoma
Published: Nov 22, 2019 | Tags: CADTHs CDEC, Hereditary Angioedema Attacks, lanadelumab injection, Positive Opinion, receives, Routine Prevention, Takeda, Takhzyro
Published: Nov 25, 2019 | Tags: Acceptance, FDA, Granted, NDA, Priority Review, reports, Risdiplam, Roche, Spinal Muscular Atrophy, Treat, US
31. Novartis to Acquire The Medicines Company for $9.7B
Published: Nov 24, 2019 | Tags: $9.7B, Acquire, Novartis, The Medicines Company
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com